Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Mifobate (Standard)
Cat. No.:
OB0425LY-002
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Mifobate (Standard) is a potent and specific PPARγ antagonist with antiobesity and antidiabetic effects.
Synonyms:
Mifobate; 76541-72-5; (4-Chlorophenyl)(dimethoxyphosphinyl)methyl phosphoric acid dimethyl ester; Phosphoric acid, (4-chlorophenyl)(dimethoxyphosphinyl)methyl dimethyl ester; (4Chlorophenyl)(dimethoxyphosphoryl)methyldimethylphosphate; [(4-Chloro-phenyl)-(dimethoxy-phosphoryloxy)-methyl]-phosphonic acid dimethyl ester
CAS No.:
76541-72-5
Compound CID:
60910
Formula:
C11H17ClO7P2
Formula Weight:
358.65
Specification
Target:
Others
Pathway:
Others
Storage:
Storage at -20°C.
Applications:
Mifobate (Standard) can be used for quantification of active ingredients in pharmaceutical preparations.
